{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:50Z","timestamp":1791337850941,"version":"4.3.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"French Ministry of Research and Higher Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"DOI":"10.1093\/sleep\/zsw010","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T06:51:27Z","timestamp":1486623087000},"source":"Crossref","is-referenced-by-count":41,"title":["Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy"],"prefix":"10.1093","volume":"40","author":[{"given":"R\u00e9gis","family":"Lopez","sequence":"first","affiliation":[{"name":"Unit\u00e9 des Troubles du Sommeil Service de Neurologie, Centre National de R\u00e9f\u00e9rence Narcolepsie Hypersomnies, H\u00f4pital Gui-de-Chauliac, Montpellier, France"},{"name":"Inserm U1061, Montpellier, France"},{"name":"Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Barateau","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Troubles du Sommeil Service de Neurologie, Centre National de R\u00e9f\u00e9rence Narcolepsie Hypersomnies, H\u00f4pital Gui-de-Chauliac, Montpellier, France"},{"name":"Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Evangelista","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Troubles du Sommeil Service de Neurologie, Centre National de R\u00e9f\u00e9rence Narcolepsie Hypersomnies, H\u00f4pital Gui-de-Chauliac, Montpellier, France"},{"name":"Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiene","family":"Chenini","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Troubles du Sommeil Service de Neurologie, Centre National de R\u00e9f\u00e9rence Narcolepsie Hypersomnies, H\u00f4pital Gui-de-Chauliac, Montpellier, France"},{"name":"Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Robert","sequence":"additional","affiliation":[{"name":"Bioprojet-Biotech, Saint Gr\u00e9goire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jaussent","sequence":"additional","affiliation":[{"name":"Inserm U1061, Montpellier, France"},{"name":"Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dauvilliers","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Troubles du Sommeil Service de Neurologie, Centre National de R\u00e9f\u00e9rence Narcolepsie Hypersomnies, H\u00f4pital Gui-de-Chauliac, Montpellier, France"},{"name":"Inserm U1061, Montpellier, France"},{"name":"Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"issue":"9560","key":"key\n\t\t\t\t20180922075222_CIT0001","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180922075222_CIT0002","volume-title":"International classification of sleep disorders\u2013third edition (ICSD-3)","author":"American Academy of Sleep Medicine","year":"2014"},{"issue":"6","key":"key\n\t\t\t\t20180922075222_CIT0003","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.5665\/sleep.3756","article-title":"Challenges in diagnosing narcolepsy without cataplexy: a consensus statement","volume":"37","author":"Baumann","year":"2014","journal-title":"Sleep"},{"issue":"8","key":"key\n\t\t\t\t20180922075222_CIT0004","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/sleep\/32.8.993","article-title":"Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy","volume":"32","author":"Thannickal","year":"2009","journal-title":"Sleep"},{"issue":"12","key":"key\n\t\t\t\t20180922075222_CIT0005","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/brain\/awt277","article-title":"Clinical and polysomnographic course of childhood narcolepsy with cataplexy","volume":"136","author":"Pizza","year":"2013","journal-title":"Brain"},{"issue":"9","key":"key\n\t\t\t\t20180922075222_CIT0006","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.5665\/sleep.2080","article-title":"Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy","volume":"35","author":"Andlauer","year":"2012","journal-title":"Sleep"},{"issue":"23","key":"key\n\t\t\t\t20180922075222_CIT0007","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1212\/WNL.0000000000001051","article-title":"Primary progressive narcolepsy type 1: the other side of the coin","volume":"83","author":"Pizza","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"key\n\t\t\t\t20180922075222_CIT0008","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.24019","article-title":"Increase of histaminergic tuberomammillary neurons in narcolepsy","volume":"74","author":"Valko","year":"2013","journal-title":"Ann Neurol"},{"issue":"6","key":"key\n\t\t\t\t20180922075222_CIT0009","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ana.23968","article-title":"Greatly increased numbers of histamine cells in human narcolepsy with cataplexy","volume":"74","author":"John","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"key\n\t\t\t\t20180922075222_CIT0010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.5665\/sleep.2114","article-title":"Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions","volume":"35","author":"Dauvilliers","year":"2012","journal-title":"Sleep"},{"issue":"1","key":"key\n\t\t\t\t20180922075222_CIT0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.sleep.2010.05.010","article-title":"The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency","volume":"12","author":"Overeem","year":"2011","journal-title":"Sleep Med"},{"issue":"6","key":"key\n\t\t\t\t20180922075222_CIT0012","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.vaccine.2012.12.014","article-title":"Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation","volume":"31","author":"Poli","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"key\n\t\t\t\t20180922075222_CIT0013","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrneurol.2014.97","article-title":"Cataplexy\u2014clinical aspects, pathophysiology and management strategy","volume":"10","author":"Dauvilliers","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"key\n\t\t\t\t20180922075222_CIT0014","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"issue":"1","key":"key\n\t\t\t\t20180922075222_CIT0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ab.2010.09.045","article-title":"Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization","volume":"409","author":"Croyal","year":"2011","journal-title":"Anal Biochem"},{"issue":"2","key":"key\n\t\t\t\t20180922075222_CIT0016","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0014-4886(03)00388-1","article-title":"Relationship between CSF hypocretin levels and hypocretin neuronal loss","volume":"184","author":"Gerashchenko","year":"2003","journal-title":"Exp Neurol"},{"issue":"1","key":"key\n\t\t\t\t20180922075222_CIT0017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5665\/sleep.2320","article-title":"Hypocretin deficiency develops during onset of human narcolepsy with cataplexy","volume":"36","author":"Savvidou","year":"2013","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20180922075222_CIT0018","doi-asserted-by":"crossref","first-page":"25162","DOI":"10.1038\/srep25162","article-title":"From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid","volume":"6","author":"Hirtz","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"key\n\t\t\t\t20180922075222_CIT0019","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"key\n\t\t\t\t20180922075222_CIT0020","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"key\n\t\t\t\t20180922075222_CIT0021","doi-asserted-by":"crossref","first-page":"e1003270","DOI":"10.1371\/journal.pgen.1003270","article-title":"ImmunoChip study implicates antigen presentation to T cells in narcolepsy","volume":"9","author":"Faraco","year":"2013","journal-title":"PLoS Genet"},{"issue":"9","key":"key\n\t\t\t\t20180922075222_CIT0022","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"issue":"7","key":"key\n\t\t\t\t20180922075222_CIT0023","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2015.99","article-title":"Interactions of the histamine and hypocretin systems in CNS disorders","volume":"11","author":"Shan","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"key\n\t\t\t\t20180922075222_CIT0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"11","key":"key\n\t\t\t\t20180922075222_CIT0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"key\n\t\t\t\t20180922075222_CIT0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000101725.34089.1E","article-title":"Effect of age on MSLT results in patients with narcolepsy\u2013cataplexy","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"issue":"10","key":"key\n\t\t\t\t20180922075222_CIT0027","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"6","key":"key\n\t\t\t\t20180922075222_CIT0028","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann. Neurol"},{"issue":"16","key":"key\n\t\t\t\t20180922075222_CIT0029","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181bd1344","article-title":"Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment","volume":"73","author":"Dauvilliers","year":"2009","journal-title":"Neurology"}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/sleep\/article-pdf\/40\/1\/zsw010\/25823921\/zsw010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T13:02:42Z","timestamp":1568811762000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsw010\/2979189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,9]]},"published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsw010","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,1,1]]},"published":{"date-parts":[[2017,1,1]]}}}